Abstract
In 1980 there was considerable confusion surrounding the management of osteosarcoma. Those involved in the management of this disease were faced with a series of conflicts. The early promise of chemotherapy as initially reported by Jaffe appeared to have been logically extended by Rosen in a series of studies culminating in the startling results of T10 wherein over 90% of patients were disease free at 2 years. However, the use of chemotherapy in Europe was producing surprisingly little improvement in survival over that achieved by amputation alone. Both the E.O.R.T.C. Studies and that undertaken by the Medical Research Council (M.R.C.) in the United Kingdom were disappointing, although in retrospect it is clear that the intensity of chemotherapy was inadequate [1,2]. At the same time the Mayo Clinic was reporting a survival of 50% with surgery alone and no chemotherapy, one of their explanations being that the natural history of the disease had changed and that chemotherapy was no longer necessary [3].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Medical Research Council (MRC). A trial of chemotherapy in patients with osteosarcoma (a report to the Medical Research Council by their Working Party on Bone Sarcoma). Br J Cancer 53:513–518, 1986.
Burgers JMV, Van Glabbeke M, Busson A, et al. Osteosarcoma of the limbs: report of the EORTC-SIOP 03 trial 20781 investigating the value of adjuvant treatment with chemotherapy and/or prophylactic lung irradiation. Cancer 5:1024–1031, 1988.
Edmondson JH, Green SJ, Ivins JC, et al. A controlled pilot study of high-dose methotrexate: a postsurgical adjuvant treatment for primary osteosarcoma. J Clin Oncol 2:156, 1984.
Link MP. Adjuvant therapy in the treatment of osteosarcoma. In: Important Advances in Oncology. De Vita VT, Helson S, Rosenberg SA, Eds. Lippincott, Philadelphia, J.B. 1986, pp 193–207.
Eilber F, Giuliano A, Edkardt J, et al. Adjuvant chemotherapy for osteosarcoma: a randomised prospective trial. J Clin Oncol 5:21–26, 1987.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media New York
About this chapter
Cite this chapter
Craft, A.W., Burgers, J.M.V. (1993). The European Osteosarcoma Intergroup (E.O.I.) studies 1980–1991. In: Humphrey, G.B., Koops, H.S., Molenaar, W.M., Postma, A. (eds) Osteosarcoma in Adolescents and Young Adults: New Developments and Controversies. Cancer Treatment and Research, vol 62. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3518-8_33
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3518-8_33
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6561-7
Online ISBN: 978-1-4615-3518-8
eBook Packages: Springer Book Archive